• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便微生物群动态及其与克罗恩病病程的关系。

Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn's Disease.

机构信息

School of Nutrition and Translational Research in Metabolism [NUTRIM], Department of Medical Microbiology, Maastricht University Medical Center+, Maastricht, The Netherlands.

School of Public Health and Primary Care [Caphri], Department of Medical Microbiology, Maastricht University Medical Center+, Maastricht, The Netherlands.

出版信息

J Crohns Colitis. 2019 Sep 27;13(10):1273-1282. doi: 10.1093/ecco-jcc/jjz049.

DOI:10.1093/ecco-jcc/jjz049
PMID:30810207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6764104/
Abstract

BACKGROUND

Microbial shifts have been associated with disease activity in Crohn's disease [CD], but findings on specific taxa are inconsistent. This may be due to differences in applied methods and cross-sectional study designs. We prospectively examined the faecal microbiota in adult CD patients with changing or stable disease course over time.

METHODS

Faeces were collected at two time-points from 15 healthy control individuals [HCs], 35 CD patients who were in remission and who maintained remission [RRs], and 22 CD patients during remission and also during subsequent exacerbation [RAs]. The microbial composition was assessed by 16S rRNA [V4] gene sequencing.

RESULTS

Compared with HCs, patients with CD had a lower microbial richness [p = 0.0002] and diversity [p = 0.005]. Moreover, the microbial community structure of a subset of patients, clustered apart from HCs, was characterized by low microbial diversity and Faecalibacterium abundance. Patients within this cluster did not differ with respect to long-term disease course compared with patients with a 'healthy-appearing' microbiota.Over time, microbial richness and diversity did not change in RR versus RA patients. Although the microbial community structure of both RR and RA patients was less stable over time compared with that of HCs, no differences were observed between the patient groups [p = 0.17]; nor was the stability impacted by Montreal classification, medication use, or surgery.

CONCLUSION

The altered microbiota composition and stability in CD was neither associated with disease activity nor long-term disease course, questioning its involvement in the development of an exacerbation. The aberrant microbiota composition in a subset of CD patients warrants further exploration of a more microbiota-driven etiology in this group.

摘要

背景

微生物群的变化与克罗恩病[CD]的疾病活动有关,但特定分类群的发现结果不一致。这可能是由于应用方法和横断面研究设计的差异所致。我们前瞻性地研究了随着时间的推移病情变化或稳定的成年 CD 患者的粪便微生物群。

方法

从 15 名健康对照[HCs]、35 名处于缓解期且保持缓解[RRs]的 CD 患者和 22 名缓解期但随后出现恶化[RAs]的 CD 患者中收集粪便。采用 16S rRNA[V4]基因测序评估微生物组成。

结果

与 HCs 相比,CD 患者的微生物丰富度[P = 0.0002]和多样性[P = 0.005]较低。此外,一部分患者的微生物群落结构与 HCs 分离,其特征是微生物多样性和粪杆菌丰度低。与具有“健康样”微生物群的患者相比,该亚群患者的长期疾病病程没有差异。RR 与 RA 患者的微生物丰富度和多样性随时间变化而无变化。尽管 RR 和 RA 患者的微生物群落结构随时间的推移不如 HCs 稳定,但两组患者之间没有差异[P = 0.17];也没有观察到疾病分类、药物使用或手术对稳定性的影响。

结论

CD 中改变的微生物群组成和稳定性与疾病活动或长期疾病病程无关,这质疑了其在恶化中的参与。CD 患者亚群中异常的微生物群组成需要进一步探索该组中更基于微生物群的病因。

相似文献

1
Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn's Disease.粪便微生物群动态及其与克罗恩病病程的关系。
J Crohns Colitis. 2019 Sep 27;13(10):1273-1282. doi: 10.1093/ecco-jcc/jjz049.
2
Fecal microbial composition of ulcerative colitis and Crohn's disease patients in remission and subsequent exacerbation.缓解期及随后病情加重期的溃疡性结肠炎和克罗恩病患者的粪便微生物组成
PLoS One. 2014 Mar 7;9(3):e90981. doi: 10.1371/journal.pone.0090981. eCollection 2014.
3
Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.克罗恩病粪便宏基因组的调控:miRNAs 作为生物标志物的作用。
World J Gastroenterol. 2018 Dec 14;24(46):5223-5233. doi: 10.3748/wjg.v24.i46.5223.
4
IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease.IL23R 保护性编码变异促进健康个体回肠微生物组中有益细菌和多样性,而不会引起炎症性肠病。
J Crohns Colitis. 2019 Mar 30;13(4):451-461. doi: 10.1093/ecco-jcc/jjy188.
5
Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.儿童克罗恩病粪便微生物群特征及其在英夫利昔单抗治疗中的动态变化。
J Crohns Colitis. 2018 Feb 28;12(3):337-346. doi: 10.1093/ecco-jcc/jjx153.
6
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.克罗恩病患者粪便微生物群落中产生丁酸盐的细菌种类丰度降低
Digestion. 2016;93(1):59-65. doi: 10.1159/000441768. Epub 2016 Jan 14.
7
Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.中国炎症性肠病患者的粪便微生物失调。
World J Gastroenterol. 2018 Apr 7;24(13):1464-1477. doi: 10.3748/wjg.v24.i13.1464.
8
Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.炎症相关的黏膜相关微生物群和肠道屏障功能在结肠克罗恩病中的差异。
Am J Physiol Gastrointest Liver Physiol. 2018 Sep 1;315(3):G420-G431. doi: 10.1152/ajpgi.00411.2017. Epub 2018 May 31.
9
Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients.粪便微生物群特征与克罗恩病患者对乌司奴单抗治疗的反应相关。
mBio. 2018 Mar 13;9(2):e02120-17. doi: 10.1128/mBio.02120-17.
10
Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn's disease.粪便微生物组成与克罗恩病患者的术后疾病进程相关。
BMC Gastroenterol. 2020 May 4;20(1):130. doi: 10.1186/s12876-020-01281-4.

引用本文的文献

1
Unveiling the diagnostic and pro-inflammatory role of crohn's disease: insights from 16 S-guided discovery and species-specific validation.揭示克罗恩病的诊断和促炎作用:来自16S引导发现和物种特异性验证的见解
BMC Gastroenterol. 2025 Jul 1;25(1):468. doi: 10.1186/s12876-025-04061-0.
2
The gut microbiota during tamoxifen therapy in patients with breast cancer.乳腺癌患者他莫昔芬治疗期间的肠道微生物群
Sci Rep. 2025 Mar 6;15(1):7874. doi: 10.1038/s41598-025-91734-1.
3
Enhanced microbiota profiling in patients with quiescent Crohn's disease through comparison with paired healthy first-degree relatives.

本文引用的文献

1
Pathogenesis and persistence of cryptoglandular anal fistula: a systematic review.肛隐窝型肛门瘘管的发病机制和持续存在:系统综述。
Tech Coloproctol. 2017 Jun;21(6):425-432. doi: 10.1007/s10151-017-1645-5. Epub 2017 Jun 15.
2
Dynamics of the human gut microbiome in inflammatory bowel disease.炎症性肠病患者的肠道微生物组动态变化。
Nat Microbiol. 2017 Feb 13;2:17004. doi: 10.1038/nmicrobiol.2017.4.
3
A microbial signature for Crohn's disease.克罗恩病的微生物特征
通过与配对的健康一级亲属比较,增强静止期克罗恩病患者的微生物群分析
Cell Rep Med. 2024 Jul 16;5(7):101624. doi: 10.1016/j.xcrm.2024.101624. Epub 2024 Jun 27.
4
Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials.基于肠道菌群的疗法在自身免疫和风湿性疾病中的疗效和安全性:80 项随机对照试验的系统评价和荟萃分析。
BMC Med. 2024 Mar 13;22(1):110. doi: 10.1186/s12916-024-03303-4.
5
Longitudinal dynamics of gut bacteriome and mycobiome interactions pre- and post-visceral surgery in Crohn's disease.克罗恩病内脏手术后肠道细菌组和真菌组相互作用的纵向动力学。
Front Cell Infect Microbiol. 2024 Jan 15;13:1275405. doi: 10.3389/fcimb.2023.1275405. eCollection 2023.
6
Fecal Supernatants from Patients with Crohn's Disease Induce Inflammatory Alterations in M2 Macrophages and Fibroblasts.克罗恩病患者粪便上清液诱导 M2 巨噬细胞和成纤维细胞的炎症改变。
Cells. 2023 Dec 27;13(1):60. doi: 10.3390/cells13010060.
7
Evaluation of Bacterial and Fungal Biomarkers for Differentiation and Prognosis of Patients with Inflammatory Bowel Disease.用于炎症性肠病患者鉴别诊断和预后评估的细菌和真菌生物标志物研究
Microorganisms. 2023 Nov 29;11(12):2882. doi: 10.3390/microorganisms11122882.
8
Heterogeneous associations of gut microbiota with Crohn's disease activity.肠道微生物群与克罗恩病活动的异质关联。
Gut Microbes. 2024 Jan-Dec;16(1):2292239. doi: 10.1080/19490976.2023.2292239. Epub 2023 Dec 17.
9
Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease.炎症性肠病中药物与微生物群相互作用的当前证据及临床相关性。
Front Microbiol. 2023 Feb 23;14:1107976. doi: 10.3389/fmicb.2023.1107976. eCollection 2023.
10
The Intake of Dicarbonyls and Advanced Glycation Endproducts as Part of the Habitual Diet Is Not Associated with Intestinal Inflammation in Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients.双羰基化合物和糖基化终产物的摄入作为习惯性饮食的一部分与炎症性肠病和肠易激综合征患者的肠道炎症无关。
Nutrients. 2022 Dec 24;15(1):83. doi: 10.3390/nu15010083.
Gut. 2017 May;66(5):813-822. doi: 10.1136/gutjnl-2016-313235. Epub 2017 Feb 7.
4
Rhea: a transparent and modular R pipeline for microbial profiling based on 16S rRNA gene amplicons.Rhea:一个基于16S rRNA基因扩增子的用于微生物谱分析的透明且模块化的R管道。
PeerJ. 2017 Jan 11;5:e2836. doi: 10.7717/peerj.2836. eCollection 2017.
5
Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease.欧洲临床肿瘤学会(ECCO)第五届科学研讨会成果(二):肛周瘘管病的病理生理学
J Crohns Colitis. 2016 Apr;10(4):377-86. doi: 10.1093/ecco-jcc/jjv228. Epub 2015 Dec 17.
6
Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease.炎症、抗生素和饮食作为小儿克罗恩病肠道微生物群的环境应激源
Cell Host Microbe. 2015 Oct 14;18(4):489-500. doi: 10.1016/j.chom.2015.09.008.
7
Cohort Profile: The Inflammatory Bowel Disease South Limburg Cohort (IBDSL).队列简介:南林堡炎症性肠病队列(IBDSL)。
Int J Epidemiol. 2017 Apr 1;46(2):e7. doi: 10.1093/ije/dyv088.
8
The effect of sampling and storage on the fecal microbiota composition in healthy and diseased subjects.采样和储存对健康及患病受试者粪便微生物群组成的影响。
PLoS One. 2015 May 29;10(5):e0126685. doi: 10.1371/journal.pone.0126685. eCollection 2015.
9
Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.儿童炎症性肠病中的粪便微生物群及其与炎症的关系。
Am J Gastroenterol. 2015 Jun;110(6):921-30. doi: 10.1038/ajg.2015.149. Epub 2015 May 19.
10
Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission.炎症性肠病的疾病活动度评估:临床指标和生物标志物无法预测内镜缓解。
Inflamm Bowel Dis. 2015 Apr;21(4):824-31. doi: 10.1097/MIB.0000000000000341.